ZNF765 and hepatocellular carcinoma: The association of ZNF765 with T cell checkpoints was evaluated to facilitate the guidance of immunotherapy in patients, as immune checkpoint therapy has been reported to bring benefits to patients with hepatocellular carcinoma [46].